Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Moodie

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The New Zealand Medical Journal|February 25, 2006
PHARMAC responds on tolterodine for overactive bladderPeter Moodie
The New Zealand Medical Journal|March 28, 2008
PHARMAC and cardiovascular health in New ZealandPeter Moodie
The New Zealand Medical Journal|June 30, 2006
More from PHARMAC on long-acting insulin analogues: insulin glargine now fundedPeter Moodie
BMJ (Clinical Research Ed.)|December 9, 1989
Research ethics committees revisitedTim Marshall, Peter Moodie
The New Zealand Medical Journal|May 26, 2005
Response to 'Exceptional circumstances and heart transplantation' letterPaul Tomlinson, Peter Moodie
The New Zealand Medical Journal|August 17, 2006
PHARMAC seeks clinical feedback on its cost-utility analysis methodologyRachel Grocott, Peter Moodie
Medical Law International|January 1, 1997
Medical research and Alzheimer's disease: a study of the hazards of conducting research on the incompetent patientPeter Moodie, Moira Wright
The Journal of Allergy and Clinical Immunology|March 10, 2004
Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devicesScott Metcalfe, Peter Moodie
The New Zealand Medical Journal|February 8, 2006
More on PHARMAC and tobacco control in New ZealandScott Metcalfe, Peter Moodie
The New Zealand Medical Journal|January 29, 2003
More about cardiovascular disease and lipid management in New ZealandScott Metcalfe, Peter Moodie
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The New Zealand Medical Journal|February 25, 2006
PHARMAC responds on tolterodine for overactive bladderPeter Moodie
The New Zealand Medical Journal|March 28, 2008
PHARMAC and cardiovascular health in New ZealandPeter Moodie
The New Zealand Medical Journal|June 30, 2006
More from PHARMAC on long-acting insulin analogues: insulin glargine now fundedPeter Moodie
BMJ (Clinical Research Ed.)|December 9, 1989
Research ethics committees revisitedTim Marshall, Peter Moodie
The New Zealand Medical Journal|May 26, 2005
Response to 'Exceptional circumstances and heart transplantation' letterPaul Tomlinson, Peter Moodie
The New Zealand Medical Journal|August 17, 2006
PHARMAC seeks clinical feedback on its cost-utility analysis methodologyRachel Grocott, Peter Moodie
Medical Law International|January 1, 1997
Medical research and Alzheimer's disease: a study of the hazards of conducting research on the incompetent patientPeter Moodie, Moira Wright
The Journal of Allergy and Clinical Immunology|March 10, 2004
Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devicesScott Metcalfe, Peter Moodie
The New Zealand Medical Journal|February 8, 2006
More on PHARMAC and tobacco control in New ZealandScott Metcalfe, Peter Moodie
The New Zealand Medical Journal|January 29, 2003
More about cardiovascular disease and lipid management in New ZealandScott Metcalfe, Peter Moodie
Pageof 4